معرفی
Richard Parker is a Senior Research Fellow at the Edinburgh Clinical Trials Unit within the Usher Institute, College of Medicine and Veterinary Medicine at The University of Edinburgh. He has been working as a medical statistician within the Edinburgh Clinical Trials Unit since 2013.
His educational background includes:
- Master in Science in Statistics from Lancaster University (2007-2008)
- Bachelor of Science in Statistics from University of St Andrews (2003-2007)
Richard's research focuses on medical statistics with particular expertise in studies of agreement, diagnostic studies, Bayesian methods, multiple testing, randomisation methods, pilot/feasibility studies, and clinical trial design. His work spans various medical domains including critical care, hepatology, multiple sclerosis, and respiratory medicine. He applies advanced statistical methodologies to analyze clinical trial data and develop robust analytical approaches for medical research.
His recent publications demonstrate trends toward methodological innovation in clinical trial design, particularly in stepped wedge cluster randomized trials, diagnostic test evaluation, and agreement studies. His work increasingly incorporates machine learning techniques for medical diagnostics and risk stratification.
Richard has been actively involved in numerous research projects including:
- Principal Investigator for 'Robust approaches for the analysis of agreement between clinical measurements' (2023-2026)
- Co-investigator for 'Clinical Validation of Optical Molecular Alveoscopy for Pneumonia Diagnosis' (2020-2026)
- Principal Investigator for 'Hypertension management during the COVID-19 pandemic' (2021-2024)
He has contributed to multiple datasets including research on spirometry predictive values for Indian population, asthma care interventions, and COPD exacerbations. His collaborative network spans multiple institutions with significant contributions to multiple sclerosis research through the MS-SMART trial.
